• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial.肺癌筛查后诊断程序的利用:国家肺癌筛查试验。
J Am Coll Radiol. 2023 Oct;20(10):1022-1030. doi: 10.1016/j.jacr.2023.03.021. Epub 2023 Jul 7.
2
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.台湾不吸烟人群和有肺癌家族史人群的低剂量 CT 筛查:一项前瞻性队列研究。
Lancet Respir Med. 2024 Feb;12(2):141-152. doi: 10.1016/S2213-2600(23)00338-7. Epub 2023 Nov 29.
3
Incidence of Head and Neck Cancer With Lung Cancer Screening: Secondary Analysis of a Randomized Controlled Trial.肺癌筛查中头颈部癌的发病率:一项随机对照试验的二次分析。
Laryngoscope. 2022 Aug;132(8):1609-1614. doi: 10.1002/lary.30006. Epub 2022 Jan 5.
4
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).Depiscan研究的基线结果:一项法国肺癌筛查随机试点试验,比较低剂量CT扫描(LDCT)和胸部X光(CXR)。
Lung Cancer. 2007 Oct;58(1):50-8. doi: 10.1016/j.lungcan.2007.05.009. Epub 2007 Jul 12.
5
Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.低剂量计算机断层扫描与胸部 X 射线筛查对头颈部癌症幸存者的第二原发肺癌发生率:一项随机临床试验的二次分析。
JAMA Otolaryngol Head Neck Surg. 2021 Dec 1;147(12):1071-1078. doi: 10.1001/jamaoto.2021.2776.
6
Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.肺癌筛查中假阳性测试结果的累积发生率:一项随机试验。
Ann Intern Med. 2010 Apr 20;152(8):505-12, W176-80. doi: 10.7326/0003-4819-152-8-201004200-00007.
7
Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.用低剂量计算机断层扫描进行肺癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377.
8
Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.尽管在国家肺癌筛查试验的低剂量计算机断层扫描和胸部 X 射线手臂中存在不同比例的显著偶然发现,但医疗费用在这两个组之间相似。
Med Care. 2018 May;56(5):403-409. doi: 10.1097/MLR.0000000000000900.
9
Screening for lung cancer: A systematic review and meta-analysis.肺癌筛查:一项系统评价与荟萃分析。
Prev Med. 2016 Aug;89:301-314. doi: 10.1016/j.ypmed.2016.04.015. Epub 2016 Apr 26.
10
Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.低剂量 CT 筛查肺癌后的影像学及诊断性检查应用。
Chest. 2020 Feb;157(2):427-434. doi: 10.1016/j.chest.2019.08.2187. Epub 2019 Sep 12.

本文引用的文献

1
Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care.全国商业保险人群肺癌筛查后程序的总费用和自付费用:估计一个疗程的护理。
J Am Coll Radiol. 2022 Jan;19(1 Pt A):35-46. doi: 10.1016/j.jacr.2021.09.015. Epub 2021 Oct 1.
2
Lung Cancer Screening in a Safety-Net Hospital: Rare Harms Inform Decision Making.肺癌筛查在一家医疗服务对象为弱势群体的医院中实施:罕见危害影响决策制定。
Ann Thorac Surg. 2022 Oct;114(4):1168-1175. doi: 10.1016/j.athoracsur.2021.07.102. Epub 2021 Sep 10.
3
Quantifying Benefits and Harms of Lung Cancer Screening in an Underserved Population: Results From a Prospective Study.定量评估服务欠缺人群中肺癌筛查的获益和危害:一项前瞻性研究的结果。
Semin Thorac Cardiovasc Surg. 2022 Summer;34(2):691-700. doi: 10.1053/j.semtcvs.2021.04.055. Epub 2021 Jun 6.
4
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.肺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.
5
Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines.利用预测模型减少 2020 年 USPSTF 肺癌筛查指南草案中持续存在的种族和民族差异。
J Natl Cancer Inst. 2021 Nov 2;113(11):1590-1594. doi: 10.1093/jnci/djaa211.
6
Updated Analysis of Complication Rates Associated With Invasive Diagnostic Procedures After Lung Cancer Screening.肺癌筛查后侵袭性诊断程序相关并发症发生率的更新分析。
JAMA Netw Open. 2020 Dec 1;3(12):e2029874. doi: 10.1001/jamanetworkopen.2020.29874.
7
Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.低剂量 CT 筛查肺癌后的影像学及诊断性检查应用。
Chest. 2020 Feb;157(2):427-434. doi: 10.1016/j.chest.2019.08.2187. Epub 2019 Sep 12.
8
Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.社区环境中肺部异常的有创性诊断程序的并发症发生率和下游医疗费用。
JAMA Intern Med. 2019 Mar 1;179(3):324-332. doi: 10.1001/jamainternmed.2018.6277.
9
Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.尽管在国家肺癌筛查试验的低剂量计算机断层扫描和胸部 X 射线手臂中存在不同比例的显著偶然发现,但医疗费用在这两个组之间相似。
Med Care. 2018 May;56(5):403-409. doi: 10.1097/MLR.0000000000000900.
10
Surgical Outcomes in a Large, Clinical, Low-Dose Computed Tomographic Lung Cancer Screening Program.大型临床低剂量计算机断层扫描肺癌筛查项目的手术结果
Ann Thorac Surg. 2015 Oct;100(4):1218-23. doi: 10.1016/j.athoracsur.2015.04.112. Epub 2015 Jul 22.

肺癌筛查后诊断程序的利用:国家肺癌筛查试验。

Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial.

机构信息

Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island; Department of Biostatistics, Brown University of Public Health, Providence, Rhode Island.

出版信息

J Am Coll Radiol. 2023 Oct;20(10):1022-1030. doi: 10.1016/j.jacr.2023.03.021. Epub 2023 Jul 7.

DOI:10.1016/j.jacr.2023.03.021
PMID:37423348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10755856/
Abstract

OBJECTIVE

To examine utilization patterns of diagnostic procedures after lung cancer screening among participants enrolled in the National Lung Screening Trial.

METHODS

Using a sample of National Lung Screening Trial participants with abstracted medical records, we assessed utilization of imaging, invasive, and surgical procedures after lung cancer screening. Missing data were imputed using multiple imputation by chained equations. For each procedure type, we examined utilization within a year after the screening or until the next screen, whichever came first, across arms (low-dose CT [LDCT] versus chest X-ray [CXR]) and by screening results. We also explored factors associated with having these procedures using multivariable negative binomial regressions.

RESULTS

After baseline screening, our sample had 176.5 and 46.7 procedures per 100 person-years for those with a false-positive and negative result, respectively. Invasive and surgical procedures were relatively infrequent. Among those who screened positive, follow-up imaging and invasive procedures were 25% and 34% less frequent in those screened with LDCT, compared with CXR. Postscreening utilization of invasive and surgical procedures was 37% and 34% lower at the first incidence screen compared with baseline. Participants with positive results at baseline were six times more likely to undergo additional imaging than those with normal findings.

DISCUSSION

Use of imaging and invasive procedures to evaluate abnormal findings varied by screening modality, with a lower rate for LDCT than CXR. Invasive and surgical workup were less prevalent after subsequent screening examinations compared with baseline screening. Utilization was associated with older age but not gender, race or ethnicity, insurance status, or income.

摘要

目的

研究国家肺癌筛查试验(National Lung Screening Trial,NLST)参与者肺癌筛查后诊断程序的使用模式。

方法

我们利用有记录摘要的 NLST 参与者样本,评估了肺癌筛查后影像学、有创性和手术程序的使用情况。使用链式方程的多重插补法处理缺失数据。对于每种程序类型,我们根据手臂(低剂量 CT [LDCT] 与胸部 X 线 [CXR])和筛查结果,在筛查后 1 年内或下一次筛查之前(以先发生者为准),评估了这些程序的使用情况。我们还使用多变量负二项回归探索了与这些程序相关的因素。

结果

在基线筛查后,对于假阳性和阴性结果的患者,其每年每 100 人分别有 176.5 次和 46.7 次程序。有创性和手术性程序相对较少。对于筛查阳性的患者,与 CXR 相比,LDCT 筛查者的随访影像学和有创性程序分别减少了 25%和 34%。与基线相比,首次发生率筛查时的侵入性和手术性程序的使用率分别降低了 37%和 34%。基线时结果阳性的患者比正常发现的患者进行额外影像学检查的可能性高 6 倍。

讨论

根据筛查方式,评估异常发现的影像学和有创性程序的使用情况有所不同,LDCT 的使用率低于 CXR。与基线筛查相比,后续筛查检查后的有创性和手术性检查较少。使用率与年龄较大相关,但与性别、种族或民族、保险状况或收入无关。